Tumor suppressor p53 can transcriptionally activate downstream genes in response to
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …

Locally advanced prostate cancer comprises approximately 20% of new prostate cancer
diagnoses. For these patients, international guidelines recommend treatment with …

PURPOSE The surrogacy of biochemical recurrence (BCR) for overall survival (OS) in
localized prostate cancer remains controversial. Herein, we evaluate the surrogacy of BCR …

Objectives To prospectively assess the safety, functional‐and oncological‐outcomes of
irreversible electroporation (IRE) as salvage therapy for radio‐recurrent focal prostate …

Background Genetically engineered mouse models (GEMMs) of cancer are powerful tools to
study mechanisms of disease progression and therapy response, yet little is known about …

Objective To assess the efficacy of 177Lu‐PNT2002, a novel radiolabelled small molecule
that binds with high affinity to prostate‐specific membrane antigen (PSMA), in combination …

Purpose To identify reasons for negative histopathology of specimens from prostate-specific
membrane antigen (PSMA) radioguided surgery (PSMA-RGS) in recurrent prostate cancer …

Simple Summary In this study, we investigated the longitudinal changes and predictive
value of multiparametric MRI (mpMRI) features of prostate cancer patients receiving Lattice …

Purpose To analyze the 10-year biochemical relapse-free survival (BRFS), locoregional
relapse-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS) in …

Results In total, 168 patients who underwent PSMA PET/CT for suspected radiorecurrent
PCa were eligible, 40 of whom were excluded for having initial cN1 disease, missing …